124 related articles for article (PubMed ID: 38936964)
21. [Investigation of mupirocin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates by phenotypic and genotypic methods].
Us T; Kural M; Yayla B; Kiremitçi A; Cetin E; Akgün Y
Mikrobiyol Bul; 2009 Jul; 43(3):353-64. PubMed ID: 19795610
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus isolated from clinical samples at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia.
Dilnessa T; Bitew A
BMC Infect Dis; 2016 Aug; 16():398. PubMed ID: 27506613
[TBL] [Abstract][Full Text] [Related]
23. In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus.
Narayanaswamy VP; Giatpaiboon SA; Uhrig J; Orwin P; Wiesmann W; Baker SM; Townsend SM
PLoS One; 2018; 13(1):e0191522. PubMed ID: 29342216
[TBL] [Abstract][Full Text] [Related]
24. Clinical and Molecular Epidemiology of an Emerging Panton-Valentine Leukocidin-Positive ST5 Methicillin-Resistant Staphylococcus aureus Clone in Northern Australia.
McGuinness SL; Holt DC; Harris TM; Wright C; Baird R; Giffard PM; Bowen AC; Tong SYC
mSphere; 2021 Feb; 6(1):. PubMed ID: 33568451
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance.
Chen W; He C; Yang H; Shu W; Cui Z; Tang R; Zhang C; Liu Q
BMC Microbiol; 2020 Jun; 20(1):183. PubMed ID: 32600253
[TBL] [Abstract][Full Text] [Related]
26. High genetic diversity of Staphylococcus aureus strains colonizing patients with epidermolysis bullosa.
van der Kooi-Pol MM; Veenstra-Kyuchukova YK; Duipmans JC; Pluister GN; Schouls LM; de Neeling AJ; Grundmann H; Jonkman MF; van Dijl JM
Exp Dermatol; 2012 Jun; 21(6):463-6. PubMed ID: 22621190
[TBL] [Abstract][Full Text] [Related]
27. New Synergistic Combination Therapy of Mupirocin and α-Pinene Against Multidrug-Resistant Clinical Strains of Methicillin-Resistant Staphylococcus aureus.
Cáceres-Guido P; Martín-Vázquez N; Ojeda-Sana A; Van Baren C; Balbarrey Z; Moreno S
P R Health Sci J; 2024 Jun; 43(2):73-78. PubMed ID: 38860960
[TBL] [Abstract][Full Text] [Related]
28. In Vitro Activity of Retapamulin and Antimicrobial Susceptibility Patterns in a Longitudinal Collection of Methicillin-Resistant Staphylococcus aureus Isolates from a Veterans Affairs Medical Center.
Harrington AT; Black JA; Clarridge JE
Antimicrob Agents Chemother; 2015 Dec; 60(3):1298-303. PubMed ID: 26666950
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of mupirocin resistance in Staphylococcus aureus isolates from a pediatric population.
Antonov NK; Garzon MC; Morel KD; Whittier S; Planet PJ; Lauren CT
Antimicrob Agents Chemother; 2015; 59(6):3350-6. PubMed ID: 25824213
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of high-level mupirocin resistance among meticillin-resistant Staphylococcus aureus isolates in a tertiary care hospital in Singapore.
Choudhury S; Krishnan PU; Ang B
J Hosp Infect; 2012 Sep; 82(1):56-7. PubMed ID: 22854355
[TBL] [Abstract][Full Text] [Related]
31. Molecular epidemiology of plasmid-mediated high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus in four Spanish health care settings.
Pérez-Roth E; Potel-Alvarellos C; Espartero X; Constela-Caramés L; Méndez-Álvarez S; Alvarez-Fernández M
Int J Med Microbiol; 2013 May; 303(4):201-4. PubMed ID: 23611629
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic and molecular characterization of Staphylococcus aureus isolates expressing low- and high-level mupirocin resistance in Nigeria and South Africa.
Shittu AO; Udo EE; Lin J
BMC Infect Dis; 2009 Jan; 9():10. PubMed ID: 19175912
[TBL] [Abstract][Full Text] [Related]
33. Mupirocin resistance in Staphylococcus aureus: A systematic review and meta-analysis.
Dadashi M; Hajikhani B; Darban-Sarokhalil D; van Belkum A; Goudarzi M
J Glob Antimicrob Resist; 2020 Mar; 20():238-247. PubMed ID: 31442624
[TBL] [Abstract][Full Text] [Related]
34. Genotypic and phenotypic characterization of methicillin-resistant Staphylococcus aureus (MRSA) clones with high-level mupirocin resistance.
González-Domínguez M; Seral C; Potel C; Sáenz Y; Álvarez M; Torres C; Castillo FJ
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):213-7. PubMed ID: 27133306
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic Resistance Trends in Methicillin-Resistant Staphylococcus aureus Isolated in Kuwait Hospitals: 2011-2015.
Udo EE; Boswihi SS
Med Princ Pract; 2017; 26(5):485-490. PubMed ID: 28977793
[TBL] [Abstract][Full Text] [Related]
36. Host-pathogen interactions in epidermolysis bullosa patients colonized with Staphylococcus aureus.
van der Kooi-Pol MM; Duipmans JC; Jonkman MF; van Dijl JM
Int J Med Microbiol; 2014 Mar; 304(2):195-203. PubMed ID: 24444717
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients.
Fuentes I; Yubero MJ; Morandé P; Varela C; Oróstica K; Acevedo F; Rebolledo-Jaramillo B; Arancibia E; Porte L; Palisson F
Int Wound J; 2023 Mar; 20(3):774-783. PubMed ID: 36787273
[TBL] [Abstract][Full Text] [Related]
38. Methicillin-resistant Staphylococcus aureus in Stockholm, Sweden: Molecular epidemiology and antimicrobial susceptibilities to ceftaroline, linezolid, mupirocin and vancomycin in 2014.
Fang H; Fröding I; Gian B; Hæggman S; Tollström UB; Ullberg M; Nord CE
J Glob Antimicrob Resist; 2016 Jun; 5():31-5. PubMed ID: 27436463
[TBL] [Abstract][Full Text] [Related]
39. Chronicity of high and low level mupirocin resistance in Staphylococcus aureus from 30 Indian hospitals.
Prakash R; Garg A; Arya R; Kumawat RK
Sci Rep; 2023 Jun; 13(1):10171. PubMed ID: 37349503
[TBL] [Abstract][Full Text] [Related]
40. Nasopharyngeal carriage, spa types and antibiotic susceptibility profiles of Staphylococcus aureus from healthy children less than 5 years in Eastern Uganda.
Kateete DP; Asiimwe BB; Mayanja R; Mujuni B; Bwanga F; Najjuka CF; Källander K; Rutebemberwa E
BMC Infect Dis; 2019 Dec; 19(1):1023. PubMed ID: 31791276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
